Literature DB >> 18367227

HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

Xuefeng Liu1, Jeffrey Roberts, Aleksandra Dakic, Yiyu Zhang, Richard Schlegel.   

Abstract

The E6 and E7 proteins of high-risk HPVs are both required for the immortalization of primary human keratinocytes and the maintenance of the malignant phenotype of HPV-positive cancer cell lines. Our previous studies have shown that E6 protein binds Myc protein and that both E6 and Myc associate with and cooperatively activate the hTERT promoter, thereby increasing cellular telomerase activity. In this study, we evaluated the role of E7 in the maintenance and activation of telomerase in immortalized and tumorigenic cells. siRNA knockdown of either E6 or E7 (or both) in HPV-immortalized cells or an HPV-positive cancer cell line reduced hTERT transcription and telomerase activity. Since telomerase was inhibited by E7 siRNA in cells that independently expressed the E6 and E7 genes, our results reveal an independent role for E7 in the maintenance of telomerase activity. However, E7 alone was insufficient to increase endogenous hTERT mRNA or telomerase activity, although it significantly augmented E6-induced hTERT transcription and telomerase activity. To further explore this apparent E7-induced promoter augmentation, we analyzed an exogenous hTERT core promoter in transduced keratinocytes. E7 alone induced the wt hTERT promoter and augmented E6-induced hTERT promoter activity. Mutation of the E2F site in the hTERT promoter abrogated the ability of E7 to induce the hTERT promoter or to enhance the ability of E6 to induce the promoter. Correspondingly, keratinocytes expressing E6 and a mutant E7 (defective for binding pRb pocket proteins) showed lower telomerase activity than cells expressing wt E6 and wt E7. Thus, HPV E7 plays a role in the maintenance of telomerase activity in stable cell lines and augments acute, E6-induced hTERT promoter activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367227      PMCID: PMC2716003          DOI: 10.1016/j.virol.2008.02.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  87 in total

1.  Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation.

Authors:  L Sherman; A Jackman; H Itzhaki; M C Stöppler; D Koval; R Schlegel
Journal:  Virology       Date:  1997-10-27       Impact factor: 3.616

2.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.

Authors:  H Stöppler; D P Hartmann; L Sherman; R Schlegel
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

4.  Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.

Authors:  M A Steller; Z Zou; J T Schiller; R Baserga
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

5.  Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.

Authors:  D L Jones; K Münger
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.

Authors:  J O Funk; S Waga; J B Harry; E Espling; B Stillman; D A Galloway
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

7.  Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.

Authors:  K Zerfass-Thome; W Zwerschke; B Mannhardt; R Tindle; J W Botz; P Jansen-Dürr
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

8.  Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.

Authors:  Kyung-Won Huh; Joseph DeMasi; Hidesato Ogawa; Yoshihiro Nakatani; Peter M Howley; Karl Münger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

9.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

10.  Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.

Authors:  H Pan; A E Griep
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

View more
  41 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells.

Authors:  Nancy Palechor-Ceron; Frank A Suprynowicz; Geeta Upadhyay; Aleksandra Dakic; Tsion Minas; Vera Simic; Michael Johnson; Christopher Albanese; Richard Schlegel; Xuefeng Liu
Journal:  Am J Pathol       Date:  2013-10-03       Impact factor: 4.307

3.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

5.  HPV E6 protein interacts physically and functionally with the cellular telomerase complex.

Authors:  Xuefeng Liu; Aleksandra Dakic; Yiyu Zhang; Yuhai Dai; Renxiang Chen; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

Review 6.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

7.  Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.

Authors:  Fang Li; Jinquan Cui
Journal:  Med Oncol       Date:  2015-06-12       Impact factor: 3.064

8.  Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells.

Authors:  Frank A Suprynowicz; Geeta Upadhyay; Ewa Krawczyk; Sarah C Kramer; Jess D Hebert; Xuefeng Liu; Hang Yuan; Chaitra Cheluvaraju; Phillip W Clapp; Richard C Boucher; Christopher M Kamonjoh; Scott H Randell; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

9.  Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.

Authors:  Ziad Sahab; Sawali R Sudarshan; Xuefeng Liu; YiYu Zhang; Alexander Kirilyuk; Christopher M Kamonjoh; Vera Simic; Yuhai Dai; Stephen W Byers; John Doorbar; Frank A Suprynowicz; Richard Schlegel
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 10.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.